1. Strauss HW, Narula J, Orellana P, Jaimovich R, Stevenson N, Gonzales G, Srivastava S (2013) Targeting of vulnerable plaque using [tin-117 m]-DOTA-annexin. J Nucl Med 54:1667
2. Simon J, Rogers JA, Frank RK, Mueller DW, Stevenson NR (2013) Sn-117 m labeled annexin for vulnerable plaque. American Chemical Society Annual meeting, New Orleans
3. Srivastava SC, Narula J, Strauss HW, Gonzales G (2013) Simultaneous imaging and treatment of vulnerable plaques with tin-117 m-DOTA-Annexin WIPR 2013. Latest progress in the field of radio immunotherapy, Nantes
4. Bishayee A, Rao DV, Srivastava SC, Bouchet LG, Bolch WE, Howell RW (2000) Marrow-sparing effects of 117mSn(4+)diethylenetriaminepentaacetic acid for radionuclide therapy of bone cancer. J Nucl Med 41:2043–2050
5. Zimmerman BE, Cessna JT, Schima FJ (1998) The standardization of the potential bone palliation radiopharmaceutical 117mSn(+4)DTPA. Appl Radiat Isot 49:317–328